Fluorescein sodium
Brand names: Minims fluorescein
Fluorescein sodium is a fluorescent diagnostic dye used in ophthalmology for applanation tonometry, contact lens fitting, detecting corneal epithelial damage and, by injection, for retinal angiography.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is an inert dye that fluoresces under blue light and pools in areas of epithelial loss or leaks from abnormal retinal vessels, making defects and vascular abnormalities visible.
Prescribing in practice
- Intravenous fluorescein for angiography can rarely cause serious anaphylactoid reactions, so resuscitation facilities must be available; topical diagnostic use is much lower risk.
- Soft contact lenses should be removed before applying topical fluorescein, as the dye can stain them.
- Patients should be warned that injected fluorescein temporarily discolours the skin and urine.
Monitoring
When given intravenously, observe the patient for hypersensitivity reactions during and shortly after administration.
Counselling the patient
- After an injection your skin may look yellowish and your urine bright orange for a short time, which is harmless.
- Remove soft contact lenses before the dye is used.
- Tell the clinician about any previous reaction to fluorescein.
Evidence & guidelines
Fluorescein is a standard ophthalmic diagnostic dye for surface staining and retinal angiography, with use guided by the SPC.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Framingham Heart Failure Diagnostic Criteria · Heart Failure
- ADAPT Protocol for Cardiac Event Risk · Chest Pain
- Pericarditis Diagnostic Score (Imazio Criteria) · Pericardial Disease
- Brugada Syndrome Diagnostic Criteria · Channelopathy / Sudden Cardiac Death
- Corrected Sodium (Hyperglycaemia) · Electrolytes
- Sensitivity / Specificity / PPV / NPV Calculator · Diagnostic Test Evaluation
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme